Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis Patients at 6, 12 and 18 Months

NCT02958319 is registered in ClinicalTrials.gov with Universidad Autonoma de Nuevo Leon as lead sponsor.

NCT NCT02958319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02958319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis Patients at 6, 12 and 18 Months
Lead sponsor
Universidad Autonoma de Nuevo Leon
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
November 26, 2018
Enrollment
278 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis